Blockchain Registration Transaction Record

Creative Biolabs Pioneers Non-IgG Antibody Development Platform

Creative Biolabs introduces a novel platform for non-IgG antibody development, overcoming challenges in yield and stability to advance biomedical research and therapeutic options.

Creative Biolabs Pioneers Non-IgG Antibody Development Platform

The development of non-IgG antibodies by Creative Biolabs represents a significant advancement in biomedical research, offering new therapeutic possibilities beyond the limitations of traditional IgG antibodies. This innovation could lead to more effective treatments for diseases where current antibody therapies fall short, potentially improving patient outcomes and expanding the arsenal of tools available to researchers and clinicians in the fight against complex diseases.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xd5cec23419e90d3bf552d471e31f1a62ecf71fd7c59664dd6693e891ac1f404f
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintwallRD22-bbd5b7e8d663f72c46a157537174a677